Relation Between Ethanol Sclerotherapy for Endometrioma Systemic Immune Milieu

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

May 21, 2020

Primary Completion Date

November 17, 2021

Study Completion Date

May 19, 2022

Conditions
Endometriosis
Interventions
DRUG

Ethanol Injection

The AEST procedure was performed as follows: vaginal walls were cleansed using vaginal povidone-iodine, a 17 gauge, 30-cm length needle was inserted through the posterior vaginal fornix into the pouch of Douglas, and the cyst was aspirated till complete disappearance of the cyst on the ultrasound scanner. The collected cystic fluid was collected into a plastic tube without an anticoagulant. The needle was maintained in its place, the syringe was removed and the cyst was flushed with saline solution until obtaining a clear liquid. Then, 96% ethanol was injected as 60% of the volume of the aspirated fluid to guard against over distension or rupture of the cyst and/or ethanol diffusion into the pelvis. The collected fluid was divided into three sterile tubes for cytological and bacteriological examinations and the study investigations. Patients were allowed to be completely recovered and were discharged home.

Trial Locations (1)

13511

Tanta university, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT05470972 - Relation Between Ethanol Sclerotherapy for Endometrioma Systemic Immune Milieu | Biotech Hunter | Biotech Hunter